Osaic Holdings’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.75K Buy
3,078
+2,783
+943% +$7.35K ﹤0.01% 6861
2026
Q1
$1.14K Sell
295
-420
-59% -$1.03K ﹤0.01% 7224
2025
Q4
$1.39K Hold
715
﹤0.01% 7184
2025
Q3
$585 Hold
715
﹤0.01% 7504
2025
Q2
$515 Buy
715
+125
+21% +$94 ﹤0.01% 7343
2025
Q1
$507 Sell
590
-160
-21% -$238 ﹤0.01% 6987
2024
Q4
$1.26K Sell
750
-3,545
-83% -$8.48K ﹤0.01% 6762
2024
Q3
$12.2K Hold
4,295
﹤0.01% 5686
2024
Q2
$10.1K Buy
4,295
+495
+13% +$1.29K ﹤0.01% 5785
2024
Q1
$11.2K Sell
3,800
-530
-12% -$1.5K ﹤0.01% 5693
2023
Q4
$12.9K Sell
4,330
-1,048
-19% -$3K ﹤0.01% 5707
2023
Q3
$17K Buy
5,378
+1,058
+24% +$3.44K ﹤0.01% 5633
2023
Q2
$16.7K Hold
4,320
﹤0.01% 5688
2023
Q1
$12K Hold
4,320
﹤0.01% 5879
2022
Q4
$8.19K Buy
4,320
+3,440
+391% +$6.64K ﹤0.01% 6041
2022
Q3
$2K Hold
880
﹤0.01% 6796
2022
Q2
$2K Hold
880
﹤0.01% 6903
2022
Q1
$4K Sell
880
-400
-31% -$1.64K ﹤0.01% 6616
2021
Q4
$7K Hold
1,280
﹤0.01% 6477
2021
Q3
$8K Buy
1,280
+200
+19% +$1.59K ﹤0.01% 6333
2021
Q2
$11K Buy
1,080
+200
+23% +$2.17K ﹤0.01% 6005
2021
Q1
$12K Buy
+880
New +$12.2K ﹤0.01% 5778

Other funds holding NAUT

Osaic Holdings's NAUT Position: Q2 2026 in Review

Osaic Holdings increased its Nautilus Biotechnolgy (NAUT) stake by 943% in Q2 2026, buying an estimated $7.35K and bringing the position to 3,078 shares worth $5.75K. The position accounts for ﹤0.01% of the portfolio, ranked #6861.

Osaic Holdings first reported a position in NAUT in Q1 2021 and has held it in 22 quarters since. The position peaked at $17K in Q3 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Osaic Holdings held 3,078 shares of Nautilus Biotechnolgy worth $5.75K as of Q2 2026.
  • Osaic Holdings bought 2,783 Nautilus Biotechnolgy shares in Q2 2026, an estimated $7.35K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6861 holding.
  • Osaic Holdings first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 22 quarters since.
  • Osaic Holdings's Nautilus Biotechnolgy position peaked at $17K in Q3 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.